Breaking News, Financial News

4Q Financials: AMRI

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI

4Q Revenue: $39.1 million (-15%)

4Q Loss: $942 thousand (earnings were $3.4 million 4Q2004)

FY Revenue: $183.9 million (+8%)

FY Earnings: $16.3 million (loss of $11.7 million FY2004)

Comments: Contract revenue from discovery services in the quarter was $8.3 million, up 18%. Contract revenue from development and small scale manufacturing services in the quarter was $7.5 million, up 19%. Contract revenue from large scale manufacturing in the quarter was $17.1 million, down 17%. Recurring royalties from Allegra in the quarter were $6.2 million, down 49%.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters